Notably, research groups might be able to apply the approach described in this study to develop treatments for other blood diseases such as β - thalassemia,
severe combined immunodeficiency (SCID), chronic
granulomatous disease, rare disorders like Wiskott - Aldrich syndrome and Fanconi anemia, and even HIV infection.